Takeda Pharmaceutical Valuation
| TKD Stock | EUR 25.01 0.12 0.48% |
At this time, the company appears to be overvalued. Takeda Pharmaceutical has a current Real Value of €23.48 per share. The regular price of the company is €25.01. Our model measures the value of Takeda Pharmaceutical from inspecting the company fundamentals such as Operating Margin of 0.13 %, shares outstanding of 1.56 B, and Return On Equity of 0.0477 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Takeda Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Takeda Pharmaceutical is based on 3 months time horizon. Increasing Takeda Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Takeda stock is determined by what a typical buyer is willing to pay for full or partial control of Takeda Pharmaceutical. Since Takeda Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Takeda Stock. However, Takeda Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.01 | Real 23.48 | Hype 25.01 | Naive 24.74 |
The real value of Takeda Stock, also known as its intrinsic value, is the underlying worth of Takeda Pharmaceutical Company, which is reflected in its stock price. It is based on Takeda Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Takeda Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Takeda Pharmaceutical helps investors to forecast how Takeda stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Takeda Pharmaceutical more accurately as focusing exclusively on Takeda Pharmaceutical's fundamentals will not take into account other important factors: Takeda Pharmaceutical Total Value Analysis
Takeda Pharmaceutical is at this time estimated to have takeover price of 71.16 B with market capitalization of 44.8 B, debt of 4.14 T, and cash on hands of 3.41 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Takeda Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
71.16 B | 44.8 B | 4.14 T | 3.41 B |
Takeda Pharmaceutical Investor Information
About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.95. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Takeda Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.58. The entity last dividend was issued on the 30th of March 2023. Takeda Pharmaceutical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Takeda Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Takeda Pharmaceutical has an asset utilization ratio of 27.08 percent. This implies that the Company is making €0.27 for each dollar of assets. An increasing asset utilization means that Takeda Pharmaceutical is more efficient with each dollar of assets it utilizes for everyday operations.Takeda Pharmaceutical Ownership Allocation
Takeda Pharmaceutical shows a total of 1.56 Billion outstanding shares. 30% of Takeda Pharmaceutical outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Takeda Pharmaceutical Profitability Analysis
The company reported the revenue of 3.57 T. Net Income was 230.06 B with profit before overhead, payroll, taxes, and interest of 2.44 T.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Takeda Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Takeda Pharmaceutical and how it compares across the competition.
About Takeda Pharmaceutical Valuation
The stock valuation mechanism determines Takeda Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Takeda Pharmaceutical. We calculate exposure to Takeda Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Takeda Pharmaceutical's related companies.Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 49578 people.
8 Steps to conduct Takeda Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Takeda Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Takeda Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Takeda Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Takeda Pharmaceutical's revenue streams: Identify Takeda Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Takeda Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Takeda Pharmaceutical's growth potential: Evaluate Takeda Pharmaceutical's management, business model, and growth potential.
- Determine Takeda Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Takeda Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Takeda Stock analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |